Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries.

[1]  B. Fagerberg,et al.  Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men. , 2007, Atherosclerosis.

[2]  R. D'Agostino,et al.  Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.

[3]  Philippe Giral,et al.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. , 2004, The Journal of clinical endocrinology and metabolism.

[4]  B. Fagerberg,et al.  Apolipoprotein B/Apolipoprotein A-I in Relation to the Metabolic Syndrome and Change in Carotid Artery Intima-Media Thickness During 3 Years in Middle-Aged Men , 2004, Stroke.

[5]  Rajesh K Kharbanda,et al.  Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. , 2004, Cardiovascular research.

[6]  K. Griendling,et al.  Reactive oxygen species in hypertension; An update. , 2004, American journal of hypertension.

[7]  M. Taskinen,et al.  Circulating Oxidized Low-Density Lipoprotein and Its Association With Carotid Intima-Media Thickness in Asymptomatic Members of Familial Combined Hyperlipidemia Families , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[9]  J. Fruchart,et al.  Atherogenic Lipoprotein Particles in Atherosclerosis , 2004, Circulation.

[10]  J. Fruchart,et al.  Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia. , 2004, Archives of medical research.

[11]  E. Jeffrey Metter,et al.  Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness , 2004 .

[12]  A. Algra,et al.  Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. , 2004, Atherosclerosis.

[13]  K. Woo,et al.  Deleterious Impact of “High Normal” Glucose Levels and Other Metabolic Syndrome Components on Arterial Endothelial Function and Intima-Media Thickness in Apparently Healthy Chinese Subjects: The CATHAY Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[14]  K. Wyne.  Free fatty acids and type 2 diabetes mellitus. , 2003, The American journal of medicine.

[15]  A. Zwinderman,et al.  Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size. , 2003, Atherosclerosis.

[16]  A. Kontush,et al.  Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[17]  G. Franceschini,et al.  Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[18]  O. Hamdy,et al.  Adipokines, inflammation, and the endothelium in diabetes , 2003, Current diabetes reports.

[19]  R. Parker,et al.  Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature. , 2003, Atherosclerosis.

[20]  G. Jermendy,et al.  Intima-media thickness of the carotid arteries in subjects with hyperinsulinaemia (insulin resistance). , 2003, Diabetes, nutrition & metabolism.

[21]  A. Nègre-Salvayre,et al.  HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF‐κB activation in smooth muscle cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[23]  M. Bond,et al.  Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). , 2002, The American journal of cardiology.

[24]  Y. Kagaya,et al.  Normal and Oxidized Low Density Lipoproteins Accumulate Deep in Physiologically Thickened Intima of Human Coronary Arteries , 2002, Laboratory Investigation.

[25]  G. Ciuffetti,et al.  Increased postprandial lipemia in patients with normolipemic peripheral arterial disease. , 2002, American heart journal.

[26]  E. Bonora,et al.  Insulin Causes Endothelial Dysfunction in Humans: Sites and Mechanisms , 2002, Circulation.

[27]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[28]  M. Aviram,et al.  Retention of Oxidized LDL by Extracellular Matrix Proteoglycans Leads to Its Uptake by Macrophages: An Alternative Approach to Study Lipoproteins Cellular Uptake , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[29]  J. Arbiser,et al.  Regulation of angiogenesis and tumorigenesis by signal transduction cascades: lessons from benign and malignant endothelial tumors. , 2000, The journal of investigative dermatology. Symposium proceedings.

[30]  E. Mannarino,et al.  Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. , 2000, Atherosclerosis.

[31]  G. Ciuffetti,et al.  Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. , 2000, American heart journal.

[32]  B. Fagerberg,et al.  The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis: The Atherosclerosis and Insulin Resistance (AIR) Study , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[33]  E. Mannarino,et al.  Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension. , 2000, American journal of hypertension.

[34]  J. Gamble,et al.  High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway , 1999, The Journal of Biological Chemistry.

[35]  K. Kröger,et al.  Atherosclerotic Lesions Are More Frequent in Femoral Arteries than in Carotid Arteries Independent of Increasing Number of Risk Factors , 1999, Angiology.

[36]  D. Konukoğlu,et al.  A study on the carotid artery intima-media thickness and its association with lipid peroxidation. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[37]  D. Horrobin,et al.  Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease. , 1997, Atherosclerosis.

[38]  P. Touboul,et al.  Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Artériel. , 1997, The American journal of clinical nutrition.

[39]  P. Ganz,et al.  Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. , 1996, The American journal of physiology.

[40]  R. Newall,et al.  Lipoproteins and the Relative Importance of Plasma Cholesterol and Triglycerides in Peripheral Arterial Disease , 1973, Angiology.

[41]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.